ARTICLE | Clinical News
Algisyl-LVR regulatory update
October 6, 2014 7:00 AM UTC
LoneStar Heart said it received CE Mark approval for its Algisyl-LVR hydrogel implant to treat advanced heart failure in patients with an enlarged left ventricle. The biologically inert polymer is inj...